These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 31410208)

  • 1. HMGB1 Promotes Prostate Cancer Development and Metastasis by Interacting with Brahma-Related Gene 1 and Activating the Akt Signaling Pathway.
    Lv DJ; Song XL; Huang B; Yu YZ; Shu FP; Wang C; Chen H; Zhang HB; Zhao SC
    Theranostics; 2019; 9(18):5166-5182. PubMed ID: 31410208
    [No Abstract]   [Full Text] [Related]  

  • 2. HMGB1 coordinates with Brahma-related gene 1 to promote epithelial-mesenchymal transition via the PI3K/Akt/mTOR pathway in BEAS-2B cells.
    Deng X; Niu Z; Hao C; Lin J; Yao W
    Exp Cell Res; 2023 Mar; 424(2):113522. PubMed ID: 36796747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsa_circ_0030586 promotes epithelial-mesenchymal transition in prostate cancer via PI3K-AKT signaling.
    Luo GC; Chen L; Fang J; Yan ZJ
    Bioengineered; 2021 Dec; 12(2):11089-11107. PubMed ID: 34852706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycyrrhizic Acid Attenuates Pulmonary Fibrosis of Silicosis by Inhibiting the Interaction between HMGB1 and BRG1 through PI3K/Akt/mTOR Pathway.
    Niu Z; Lin J; Hao C; Xu X; Wang C; Dai K; Deng X; Deng M; Guo Y; Yao W
    Int J Environ Res Public Health; 2022 Jul; 19(14):. PubMed ID: 35886594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sin1 promotes proliferation and invasion of prostate cancer cells by modulating mTORC2-AKT and AR signaling cascades.
    Huang Y; Feng G; Cai J; Peng Q; Yang Z; Yan C; Yang L; Wang Z
    Life Sci; 2020 May; 248():117449. PubMed ID: 32088212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-kinase-interacting protein 1 promotes EMT and metastasis via PI3K/Akt/IKKβ pathway in cervical cancer.
    Zhang X; Liu S; Zhu Y
    Cell Biochem Funct; 2020 Aug; 38(6):782-791. PubMed ID: 32401379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway.
    Zhang J; Shao S; Han D; Xu Y; Jiao D; Wu J; Yang F; Ge Y; Shi S; Li Y; Wen W; Qin W
    Int J Oncol; 2018 Aug; 53(2):659-671. PubMed ID: 29845254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The miR-218/GAB2 axis regulates proliferation, invasion and EMT via the PI3K/AKT/GSK-3β pathway in prostate cancer.
    Tian J; Zhang H; Mu L; Wang M; Li X; Zhang X; Xie E; Ma M; Wu D; Du Y
    Exp Cell Res; 2020 Sep; 394(1):112128. PubMed ID: 32522441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
    Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
    Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HPV E7-mediated NCAPH ectopic expression regulates the carcinogenesis of cervical carcinoma via PI3K/AKT/SGK pathway.
    Wang M; Qiao X; Cooper T; Pan W; Liu L; Hayball J; Lin J; Cui X; Zhou Y; Zhang S; Zou Y; Zhang R; Wang X
    Cell Death Dis; 2020 Dec; 11(12):1049. PubMed ID: 33311486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXS1 acts as an oncogene and induces EMT through FAK/PI3K/AKT pathway by upregulating HILPDA in prostate cancer.
    Ren R; Wang H; Xu Y; Wu J; Ma D; Guan W
    FASEB J; 2024 May; 38(10):e23698. PubMed ID: 38780613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
    Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
    Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
    Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
    J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of high mobility group box 1 (HMGB1) attenuates podocyte apoptosis and epithelial-mesenchymal transition by regulating autophagy flux.
    Jin J; Gong J; Zhao L; Zhang H; He Q; Jiang X
    J Diabetes; 2019 Oct; 11(10):826-836. PubMed ID: 30864227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
    Hong X; Yu JJ
    Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breviscapine suppresses the growth and metastasis of prostate cancer through regulating PAQR4-mediated PI3K/Akt pathway.
    Ye J; Gao M; Guo X; Zhang H; Jiang F
    Biomed Pharmacother; 2020 Jul; 127():110223. PubMed ID: 32413672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of TRIM47 inhibits breast cancer tumorigenesis and progression through the inactivation of PI3K/Akt pathway.
    Wang Y; Liu C; Xie Z; Lu H
    Chem Biol Interact; 2020 Feb; 317():108960. PubMed ID: 31981573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
    Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
    Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nimotuzumab inhibits epithelial-mesenchymal transition in prostate cancer by targeting the Akt/YB-1/AR axis.
    Hu S; Duan YX; Zhou Q; Wang Y; Lu Q
    IUBMB Life; 2019 Jul; 71(7):928-941. PubMed ID: 30907986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.